Intas launches DCGI-approved Tofacitinib Topical JAKi in Auto-Immune Condition Atopic Dermatitis AD for Indian patients

(This story has not been edited by THE WEEK and is auto-generated from a PTI

Related Keywords

India ,Mumbai ,Maharashtra ,Delhi ,Ahmedabad ,Gujarat ,Vibhuti Bhatt ,Kabir Sardana ,Satish Udare ,Advertising Communication Services Ltd ,Intas Pharmaceuticals ,Intas Pharmaceuticals Ltd ,Prnewswire Intas Pharmaceuticals Ltd ,Pharmaceuticals Ltd ,Tofacitinib Ointment ,Atopic Dermatitis ,Topical Calcineurin Inhibitors ,Senior Consultant Dermatologist ,Alok Chaturvedi ,Associate Executive Vice President ,Head Medical Affairs ,Active Pharmaceutical Ingredients , ,